PCN17 Health-Related Quality of Life (HRQOL) of ALK-Rearranged NON-SMALL CELL LUNG Cancer (NSCLC) Patients Treated in Second LINE with Alectinib
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.154
https://www.valueinhealthjournal.com/article/S1098-3015(20)32410-4/fulltext
Title :
PCN17 Health-Related Quality of Life (HRQOL) of ALK-Rearranged NON-SMALL CELL LUNG Cancer (NSCLC) Patients Treated in Second LINE with Alectinib
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32410-4&doi=10.1016/j.jval.2020.08.154
First page :
Section Title :
Open access? :
No
Section Order :
10110